Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTAX:US

29.19 USD 0.53 1.78%

As of 09:29:30 ET on 04/17/2015.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTAX)

Year To Date: +18.23% 3-Month: +12.75% 3-Year: +45.98% 52-Week Range: 17.51 - 30.12
1-Month: -0.75% 1-Year: +65.13% 5-Year: +32.44% Beta vs MXWO: 1.04

Mutual Fund Chart for FBTAX

No chart data available.
  • FBTAX:US 29.19
  • 1M
  • 1Y
Interactive FBTAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTAX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTAX

NAV (on 2015-04-17) 29.19
Assets (M) (on 2015-03-31) 3,110.57
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTAX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-12) 0.42
Dividend Yield (ttm) 2.07

Fees & Expenses for FBTAX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.25
Expense Ratio 1.08

Top Fund Holdings for FBTAX

Filing Date: 02/28/2015
Name Position Value % of Total
Gilead Sciences Inc 2,767,007 286,468,235 10.075%
Celgene Corp 1,700,603 206,674,283 7.268%
Biogen Inc 490,331 200,834,674 7.063%
Alexion Pharmaceuticals Inc 698,524 125,992,774 4.431%
Vertex Pharmaceuticals Inc 916,326 109,436,814 3.849%
Regeneron Pharmaceuticals Inc 260,071 107,627,783 3.785%
BioMarin Pharmaceutical Inc 812,338 86,977,030 3.059%
Pharmacyclics Inc 340,830 73,595,422 2.588%
Incyte Corp 732,299 62,867,869 2.211%
Amgen Inc 387,830 61,168,548 2.151%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil